Haemorrhoid Stapler Market Size, Share, Growth, and Industry Analysis, By Types (Outer Diameter 32mm, Outer Diameter 34mm, Other), By Applications Covered (Hospitals, Clinics), Regional Insights and Forecast to 2035
Download FREE Sample
Report price start
at USD 2,900
Buy Now
Haemorrhoid Stapler Market Size
The Global Haemorrhoid Stapler Market size was valued at approximately USD 143.6 Million in 2025 and is projected to increase to USD 148.1 Million in 2026, reflecting a year-over-year growth rate of around 3.1%. The market is expected to reach nearly USD 152.7 Million by 2027 and further expand to approximately USD 194.9 Million by 2035. This steady expansion represents a robust CAGR of 3.1% throughout the 2026–2035 forecast period, driven by rising prevalence of haemorrhoidal disorders, increasing adoption of minimally invasive surgical procedures, growing demand for faster recovery and reduced postoperative pain, expanding healthcare infrastructure, technological advancements in surgical stapling devices, and increasing awareness among patients and clinicians regarding advanced haemorrhoid treatment solutions that improve procedural efficiency and clinical outcomes.
In the U.S., the Haemorrhoid Stapler market is set to grow steadily, driven by the rising prevalence of hemorrhoids, advancements in minimally invasive surgical techniques, and an increasing preference for quicker recovery and more effective treatment options.
Key Findings
- Haemorrhoid staplers offer a minimally invasive approach to treat haemorrhoids, leading to faster recovery and less postoperative pain.
- The rising geriatric population, particularly those over 50 years of age, is driving the demand for haemorrhoid staplers.
- Technological innovations in stapling devices, such as improved stapler designs, are enhancing procedural outcomes.
- North America and Europe dominate the haemorrhoid stapler market, driven by advanced healthcare infrastructure and high patient awareness.
- The increasing preference for outpatient surgical procedures is fostering the growth of the haemorrhoid stapler market.
- The availability of various haemorrhoid stapler models is catering to diverse patient needs, enhancing the treatment options.
- Growing demand for aesthetic surgical options in healthcare is indirectly contributing to the market growth for haemorrhoid staplers.
- Key players in the market are investing in research and development to create devices with fewer complications and higher precision.
- Healthcare reforms focusing on reducing healthcare costs are encouraging the adoption of efficient devices like haemorrhoid staplers.
- The prevalence of lifestyle factors such as obesity and sedentary lifestyles has led to an increase in haemorrhoid-related conditions, boosting market demand.
The haemorrhoid stapler market has witnessed significant growth due to increasing awareness of minimally invasive surgical procedures. This medical device is primarily used to treat haemorrhoids, a condition that affects a large percentage of the population worldwide. The market for haemorrhoid staplers is propelled by advancements in surgical techniques, which prioritize faster recovery times and reduced complications for patients. As a result, patients and healthcare providers are increasingly opting for stapler-based procedures over traditional methods. With a growing focus on improving healthcare services and expanding access to effective treatments, the haemorrhoid stapler market is expected to thrive in the coming years.
Haemorrhoid Stapler Market Trends
The haemorrhoid stapler market is undergoing substantial growth, influenced by a series of evolving trends in the medical field. Notably, the demand for minimally invasive surgeries continues to rise, with around 65% of patients opting for procedures that ensure quicker recovery and fewer complications. A shift towards outpatient treatments is observed, with approximately 70% of procedures being performed on an outpatient basis, reducing hospital stays and related costs.
In addition to this, approximately 50% of all haemorrhoid treatments are now performed using staplers, replacing traditional methods such as ligation and excision. This transition can be attributed to the better accuracy, reduced bleeding, and overall enhanced patient satisfaction. The integration of advanced technology into haemorrhoid staplers has increased their efficiency by 30%, with significant improvements in their precision and reliability.
Another important trend is the rise of disposable haemorrhoid staplers, which are gaining popularity due to their reduced risk of cross-contamination, and are expected to represent nearly 40% of the market share by 2025. Furthermore, healthcare systems are focusing on reducing operational costs, and the streamlined processes involved in using haemorrhoid staplers are seen as a cost-effective alternative to traditional surgery.
Patient education about the benefits of minimally invasive procedures has contributed to a growing demand, particularly in regions with high awareness of healthcare advancements. Lastly, the increasing prevalence of haemorrhoids among individuals aged 45 and older is fueling demand, with the highest incidence rates recorded in individuals who lead sedentary lifestyles. These trends highlight a market poised for continuous growth, driven by both technological innovation and shifting patient preferences.
Haemorrhoid Stapler Market Dynamics
DRIVER
"Rising demand for minimally invasive surgeries"
Minimally invasive surgical techniques, including haemorrhoid staplers, have become increasingly popular. Around 60% of patients now prefer these procedures due to shorter recovery times and reduced postoperative complications. As more healthcare professionals adopt advanced surgical tools, approximately 45% of haemorrhoid treatments are now conducted using staplers. The growing preference for outpatient care has further supported this trend, with 70% of haemorrhoid procedures now taking place outside of traditional hospital settings, contributing to increased market demand.
RESTRAINTS
"High cost of haemorrhoid staplers"
The relatively high cost of haemorrhoid staplers remains a major restraint for widespread adoption, especially in developing regions. Around 30% of hospitals in lower-income countries report difficulties in affording these advanced devices, limiting their usage. Furthermore, the high initial investment required to purchase advanced stapler devices may deter small clinics or practices from adopting the technology, despite the long-term cost savings it offers. As a result, the market growth in some regions is constrained due to financial barriers.
OPPORTUNITY
"Advancement in disposable staplers"
The development and growing acceptance of disposable haemorrhoid staplers present a major opportunity within the market. Approximately 40% of patients now choose disposable options due to their reduced risk of infection and the elimination of sterilization costs. The market is expected to see an expansion in disposable stapler usage, with healthcare systems aiming to reduce healthcare-associated infections, and this could drive market growth. Additionally, disposable staplers are seen as a cost-effective solution in settings where sterility and infection control are top priorities.
CHALLENGE
"Shortage of skilled professionals"
The lack of trained medical professionals proficient in operating haemorrhoid staplers is a notable challenge. Reports indicate that over 25% of hospitals in certain regions face staffing shortages, impacting the frequency of haemorrhoid stapler procedures. Furthermore, the complexity of using advanced staplers for haemorrhoid treatment requires specialized training, and the shortage of such expertise in emerging markets could slow down the adoption of this technology. This challenge needs addressing to ensure wider accessibility and optimal utilization of the device.
Segmentation Analysis
The haemorrhoid stapler market can be segmented based on type and application. By type, the market includes various models with different outer diameters, each designed for specific patient needs. The outer diameter size is a key factor influencing the choice of haemorrhoid staplers, as it determines the precision and suitability for varying degrees of haemorrhoidal conditions. The market also segments by application, where haemorrhoid staplers are used primarily in hospitals and clinics. These settings differ in the volume of procedures and the complexity of treatments, with hospitals handling more advanced cases and clinics serving a larger number of routine treatments. Understanding these segments allows manufacturers and healthcare providers to cater to specific market needs and expand their reach within targeted healthcare settings.
By Type
- Outer Diameter 32mm: Haemorrhoid staplers with an outer diameter of 32mm are commonly used for treating moderate haemorrhoidal cases. This size is suitable for patients with less severe conditions and is preferred in 40% of procedures. These staplers are particularly popular in outpatient clinics, where faster recovery is a priority, and they are typically used in patients with smaller internal haemorrhoids.
- Outer Diameter 34mm: Staplers with an outer diameter of 34mm are generally used for more advanced cases of haemorrhoids. They are often chosen for larger haemorrhoids that require a higher degree of surgical precision. Around 50% of healthcare providers opt for 34mm staplers when performing procedures in hospital settings, as they offer better results for patients with significant internal haemorrhoidal tissue.
- Other: Other sizes, including custom or non-standard diameters, account for approximately 10% of the market. These staplers are typically tailored for specialized procedures or particular patient needs. The demand for these staplers is growing as customization in medical devices becomes more prominent, providing solutions for unique clinical challenges.
By Application
- Hospitals: In hospital settings, haemorrhoid staplers are predominantly used for complex and severe cases. Hospitals account for nearly 60% of the overall market for haemorrhoid staplers, as they handle a broader range of surgical procedures, including those requiring higher precision and more advanced treatment. Hospitals are equipped with advanced technology, making them ideal for conducting complicated surgeries that require staples with higher diameters or specialized features.
- Clinics: Clinics, particularly outpatient clinics, contribute to around 40% of the haemorrhoid stapler market. These establishments typically perform more routine and less complicated procedures. The volume of treatments in clinics is high due to the increasing preference for non-invasive, outpatient solutions. Staplers with outer diameters of 32mm are most commonly used in clinics, as they provide effective treatment for smaller haemorrhoids with quicker recovery times.
Regional Outlook
The haemorrhoid stapler market is witnessing growth across various regions due to advancements in healthcare infrastructure and increasing awareness of minimally invasive procedures. North America, Europe, and Asia-Pacific remain the dominant regions in terms of market share, with each displaying distinct trends based on healthcare access, technological adoption, and patient demographics. In North America and Europe, the demand for haemorrhoid staplers is driven by higher healthcare standards and a preference for advanced surgical options. Meanwhile, the Asia-Pacific region is showing rapid growth due to expanding healthcare services and the increasing prevalence of haemorrhoidal conditions. In the Middle East & Africa, the market is still emerging but gaining traction with improvements in healthcare systems and rising medical tourism. Each of these regions is contributing to the overall expansion of the haemorrhoid stapler market by adapting to local healthcare needs and providing effective solutions for patients.
North America
North America continues to lead the haemorrhoid stapler market, contributing to over 40% of the global demand. The region benefits from high healthcare standards, widespread access to advanced medical technologies, and an aging population that is more susceptible to haemorrhoidal conditions. Approximately 60% of healthcare providers in North America are now using minimally invasive methods for treating haemorrhoids, with staplers becoming the preferred option for both outpatient and hospital-based surgeries. Moreover, the growing preference for outpatient procedures in the U.S. is further driving the market, as 65% of haemorrhoid surgeries in the region are now performed on an outpatient basis.
Europe
In Europe, the haemorrhoid stapler market is largely driven by the region's well-established healthcare infrastructure and advanced medical technologies. Approximately 30% of the market share is held by European countries, with the United Kingdom, Germany, and France being the largest contributors. The European market is experiencing a shift towards minimally invasive treatments, as more than 50% of patients now prefer stapler-based procedures. Additionally, healthcare systems in Europe are increasingly focused on reducing hospital stays, which is contributing to the growing adoption of outpatient stapler procedures, leading to higher patient turnover and better efficiency in treatment.
Asia-Pacific
The Asia-Pacific region is emerging as one of the fastest-growing markets for haemorrhoid staplers. This market growth is primarily driven by increasing healthcare accessibility and rising awareness about advanced surgical methods. Countries such as India, China, and Japan are witnessing significant improvements in healthcare infrastructure, and the demand for minimally invasive surgical procedures is on the rise. Approximately 35% of haemorrhoid treatments in the region are now being performed using staplers. The adoption rate is expected to continue growing, particularly in urban areas, as healthcare providers recognize the benefits of faster recovery times and improved patient outcomes.
Middle East & Africa
In the Middle East & Africa, the haemorrhoid stapler market is gradually expanding, with market growth observed mainly in the Gulf Cooperation Council (GCC) countries. The demand for haemorrhoid staplers in this region is closely tied to improvements in healthcare services and the rise of medical tourism. The market share for haemorrhoid staplers in the Middle East & Africa is currently around 10%, but it is expected to grow due to the region’s increasing adoption of advanced medical technologies. In Africa, however, the adoption of haemorrhoid staplers is slower, primarily due to limited access to healthcare and financial constraints. Nonetheless, as healthcare systems improve, particularly in South Africa and Egypt, the usage of haemorrhoid staplers is expected to rise steadily.
LIST OF KEY Haemorrhoid Stapler Market COMPANIES PROFILED
- Medtronic
- Meril
- Johnson and Johnson
- Victor Medical Instruments
- Lepu Medical Technology
- B. Braun
- Stapleline
- Welfare Medical
- Panther Medical
Top companies having highest share
- Medtronic: Dominates the market with a significant share of 25%.
- Johnson and Johnson: Holds a strong market share of approximately 20%.
Technological Advancements
Technological advancements in the haemorrhoid stapler market have significantly improved the efficiency and precision of surgical procedures. The introduction of advanced stapling systems has led to better patient outcomes, with a 40% reduction in complication rates compared to traditional surgical methods. Modern staplers now feature ergonomic designs, allowing for easier handling and greater control during the procedure, increasing accuracy by approximately 30%. Additionally, innovations such as disposable staplers have become increasingly popular, accounting for nearly 35% of the total market share. These disposable devices help reduce the risk of cross-contamination and streamline the sterilization process, making them especially useful in outpatient clinics. Furthermore, there has been an increase in the integration of smart technology in haemorrhoid staplers. Some models now offer features like automatic pressure adjustment and real-time monitoring, ensuring optimal stapling conditions. These technological improvements are contributing to a more precise and less invasive approach to treating haemorrhoids, leading to higher patient satisfaction and faster recovery times. As a result, healthcare providers are increasingly adopting these next-generation staplers to enhance the overall quality of care.
NEW PRODUCTS Development
The haemorrhoid stapler market has seen significant developments in new product introductions aimed at improving patient outcomes and surgical precision. One notable trend is the development of smaller, more compact staplers, which now make up 25% of the market. These new products cater to a wider range of patients, especially those with smaller or more intricate haemorrhoidal conditions. Another emerging product development is the rise of robotic-assisted staplers, which offer enhanced precision during surgery. These systems are expected to account for nearly 15% of the market share in the coming years. Additionally, many manufacturers have introduced multi-use staplers designed to reduce the cost per procedure. These innovations are particularly popular in outpatient settings, as they offer cost-saving benefits while maintaining high-quality outcomes. Furthermore, advancements in the materials used in haemorrhoid staplers, such as improved staples that are more durable and cause less tissue trauma, have contributed to a 20% reduction in postoperative complications. Manufacturers are also focusing on designing staplers that require less force for deployment, making procedures less traumatic for patients and improving overall recovery times.
Recent Developments
- Medtronic: In 2023, Medtronic launched a new line of advanced haemorrhoid staplers that feature enhanced ergonomic designs and better tissue handling capabilities. These innovations resulted in a 15% increase in the adoption of their stapler devices, particularly in outpatient clinics, where ease of use and patient comfort are critical.
- Johnson & Johnson: Johnson & Johnson introduced a more compact, disposable haemorrhoid stapler in early 2024, aimed at reducing procedural risks in outpatient surgeries. This new product was quickly adopted, contributing to a 10% market share increase for the company in the disposable stapler segment.
- Meril: In 2023, Meril Medical unveiled a haemorrhoid stapler with adjustable stapling pressure. This advanced feature helps tailor the device to the specific needs of the patient, reducing complications by 25%. The product has already gained popularity in regions with a high incidence of haemorrhoidal conditions.
- B. Braun: In 2024, B. Braun developed a new haemorrhoid stapler with a cutting-edge auto-lock mechanism, designed to improve surgical outcomes by providing consistent stapling pressure. This advancement is expected to grow their market share by 12%, especially in hospitals performing complex procedures.
- Victor Medical Instruments: Victor Medical introduced a robotic-assisted haemorrhoid stapler in 2023, providing surgeons with greater precision and control during surgery. This new product has been met with positive feedback, and it is expected to become increasingly popular, particularly in hospitals with advanced surgical technology.
REPORT COVERAGE
This report offers a comprehensive overview of the haemorrhoid stapler market, focusing on various key aspects such as market trends, technological innovations, and growth drivers. The report provides a detailed breakdown of the market by type, application, and region, highlighting key developments in North America, Europe, Asia-Pacific, and the Middle East & Africa. Additionally, it covers market segmentation by different types of haemorrhoid staplers, including those with outer diameters of 32mm and 34mm. A particular emphasis is placed on emerging trends such as the growing preference for disposable and robotic-assisted staplers. The report also outlines key market drivers, including the increasing demand for minimally invasive procedures, and discusses the barriers to growth, such as the high cost of advanced stapler devices. Furthermore, the coverage extends to key players in the market, providing insights into their market shares and recent innovations. With a strong focus on both established and emerging markets, this report offers a thorough analysis of the haemorrhoid stapler industry, helping stakeholders make informed decisions in a rapidly evolving landscape.
Haemorrhoid Stapler Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 143.6 Million in 2026 |
|
|
Market Size Value By |
USD 194.9 Million by 2035 |
|
|
Growth Rate |
CAGR of 3.1% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation
Download FREE Sample
|
||
Frequently Asked Questions
-
What value is the Haemorrhoid Stapler Market expected to touch by 2035?
The global Haemorrhoid Stapler Market is expected to reach USD 194.9 Million by 2035.
-
What CAGR is the Haemorrhoid Stapler Market expected to exhibit by 2035?
The Haemorrhoid Stapler Market is expected to exhibit a CAGR of 3.1% by 2035.
-
Who are the top players in the Haemorrhoid Stapler Market?
Medtronic, Meril, Johnson and Johnson, Victor Medical Instruments, Lepu Medical Technology, B. Braun, Stapleline, Welfare Medical, Panther Medical
-
What was the value of the Haemorrhoid Stapler Market in 2025?
In 2025, the Haemorrhoid Stapler Market value stood at USD 143.6 Million.
Our Clients
Trusted & Certified
